Reporter Cell Lines for the Characterization of the Interactions between Human Nuclear Receptors and Endocrine Disruptors

Endocrine-disrupting chemicals (EDCs) are exogenous substances interfering with hormone biosynthesis, metabolism, or action, and consequently causing disturbances in the endocrine system. Various pathways are activated by EDCs, including interactions with nuclear receptors (NRs), which are primary targets of numerous environmental contaminants. The main NRs targeted by environmental contaminants are the estrogen (ER α, β) and the androgen (AR) receptors. ERs and AR have pleiotropic regulatory roles in a diverse range of tissues, notably in the mammary gland, the uterus, and the prostate. Thus, dysfunctional ERs and AR signaling due to inappropriate exposure to environmental pollutants may lead to hormonal cancers and infertility. The pregnane X receptor (PXR) is also recognized by many environmental molecules. PXR has a protective role of the body through its ability to regulate proteins involved in the metabolism, the conjugation, and the transport of many exogenous and endogenous compounds. However, the permanent activation of this receptor by xenobiotics may lead to premature drug metabolism, the formation, and accumulation of toxic metabolites and defects in hormones homeostasis. The activity of other NRs can also be affected by environmental molecules. Compounds capable of inhibiting or activating the estrogen related (ERRγ), the thyroid hormone (TRα, β), the retinoid X receptors (RXRα, β, γ), and peroxisome proliferator-activated (PPAR α, γ) receptors have been identified and are highly suspected to promote developmental, reproductive, neurological, or metabolic diseases in humans and wildlife. In this review, we provide an overview of reporter cell lines established to characterize the human NR activities of a large panel of EDCs including natural as well as industrial compounds such as pesticides, plasticizers, surfactants, flame retardants, and cosmetics.

[1]  Taosheng Chen,et al.  Targeting xenobiotic receptors PXR and CAR in human diseases. , 2015, Drug discovery today.

[2]  M. Hoffmann,et al.  Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. , 2015, Toxicology letters.

[3]  V. Giguère,et al.  The multiple universes of estrogen-related receptor α and γ in metabolic control and related diseases , 2014, Acta Pharmacologica Sinica.

[4]  Mariana F. Fernández,et al.  Assessment of estrogenic and anti-androgenic activities of the mycotoxin zearalenone and its metabolites using in vitro receptor-specific bioassays. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[5]  A. Kortenkamp Low dose mixture effects of endocrine disrupters and their implications for regulatory thresholds in chemical risk assessment. , 2014, Current opinion in pharmacology.

[6]  J. Fitzgerald,et al.  Gout Guidelines: The Good, the Bad, and the Future , 2014 .

[7]  W. Bourguet,et al.  Structural and Functional Profiling of Environmental Ligands for Estrogen Receptors , 2014, Environmental health perspectives.

[8]  P. Crettaz,et al.  Additive and synergistic antiandrogenic activities of mixtures of azol fungicides and vinclozolin. , 2014, Toxicology and applied pharmacology.

[9]  Ruben Abagyan,et al.  In silico identification and pharmacological evaluation of novel endocrine disrupting chemicals that act via the ligand-binding domain of the estrogen receptor α. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  F. Gonzalez,et al.  Bisphenol A Increases Atherosclerosis in Pregnane X Receptor‐Humanized ApoE Deficient Mice , 2014, Journal of the American Heart Association.

[11]  Hélène Budzinski,et al.  Identification of synthetic steroids in river water downstream from pharmaceutical manufacture discharges based on a bioanalytical approach and passive sampling. , 2014, Environmental science & technology.

[12]  J. Olivero-Verbel,et al.  Computer-aided identification of novel protein targets of bisphenol A. , 2013, Toxicology letters.

[13]  Mariana F. Fernández,et al.  In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors. , 2013, Toxicology and applied pharmacology.

[14]  Daniela Schuster,et al.  In silico methods in the discovery of endocrine disrupting chemicals , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  E. Margeat,et al.  Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells. , 2013, Molecular endocrinology.

[16]  J. M. Suh,et al.  PPARγ signaling and metabolism: the good, the bad and the future , 2013, Nature Medicine.

[17]  F. Plénat,et al.  An Alkylphenol Mix Promotes Seminoma Derived Cell Proliferation through an ERalpha36-Mediated Mechanism , 2013, PloS one.

[18]  Takahiro Matsumoto,et al.  The androgen receptor in health and disease. , 2013, Annual review of physiology.

[19]  Jean-Luc Pons,et al.  Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes , 2012, Proceedings of the National Academy of Sciences.

[20]  B. Blumberg,et al.  Obesogens, stem cells and the developmental programming of obesity. , 2012, International journal of andrology.

[21]  Paloma Alonso-Magdalena,et al.  Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways , 2012, Molecular and Cellular Endocrinology.

[22]  T. Hosaka,et al.  Establishment of a stable human cell line, HPL-A3, for use in reporter gene assays of cytochrome P450 3A inducers. , 2012, Biological & pharmaceutical bulletin.

[23]  Jean-Philippe Antignac,et al.  Occurrence of androgens in sewage treatment plants influents is associated with antagonist activities on other steroid receptors. , 2012, Water research.

[24]  J. Michiels,et al.  GPR30, the Non-Classical Membrane G Protein Related Estrogen Receptor, Is Overexpressed in Human Seminoma and Promotes Seminoma Cell Proliferation , 2012, PloS one.

[25]  Pierre Crettaz,et al.  Antiandrogenic activity of phthalate mixtures: validity of concentration addition. , 2012, Toxicology and applied pharmacology.

[26]  D. Zalko,et al.  Parallel biotransformation of tetrabromobisphenol A in Xenopus laevis and mammals: Xenopus as a model for endocrine perturbation studies. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  Wei Xu,et al.  Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands. , 2011, Biochemical pharmacology.

[28]  D. Zalko,et al.  Characterization of novel ligands of ERα, Erβ, and PPARγ: the case of halogenated bisphenol A and their conjugated metabolites. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  Lei Wang,et al.  Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. , 2011, The Journal of clinical investigation.

[30]  L. Nagy,et al.  PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation☆ , 2011, Biochimica et biophysica acta.

[31]  B. van der Burg,et al.  Stable reporter cell lines for peroxisome proliferator-activated receptor γ (PPARγ)-mediated modulation of gene expression. , 2011, Analytical biochemistry.

[32]  D. Zalko,et al.  Peroxisome Proliferator-Activated Receptor γ Is a Target for Halogenated Analogs of Bisphenol A , 2011, Environmental health perspectives.

[33]  Albertinka J Murk,et al.  Detection of thyroid hormone receptor disruptors by a novel stable in vitro reporter gene assay. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[34]  K. Horie-Inoue,et al.  Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[35]  F. Brion,et al.  Anti-androgenic activities of environmental pesticides in the MDA-kb2 reporter cell line. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[36]  Seema Negi,et al.  Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders , 2010, Molecular and Cellular Biochemistry.

[37]  Juliette Legler,et al.  Optimization and prevalidation of the in vitro ERalpha CALUX method to test estrogenic and antiestrogenic activity of compounds. , 2010, Reproductive toxicology.

[38]  Jian Li,et al.  In vitro profiling of endocrine disrupting effects of phenols. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[39]  P. Ascenzi,et al.  Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. , 2009, Molecular aspects of medicine.

[40]  Sari Mäkelä,et al.  Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. , 2009, Journal of molecular endocrinology.

[41]  L. Giudice,et al.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.

[42]  F. Grün,et al.  Endocrine disrupters as obesogens , 2009, Molecular and Cellular Endocrinology.

[43]  William Bourguet,et al.  Activation of RXR–PPAR heterodimers by organotin environmental endocrine disruptors , 2009, EMBO reports.

[44]  F. Fang,et al.  Kaempferol is an estrogen‐related receptor α and γ inverse agonist , 2009, FEBS letters.

[45]  J. Molina-Molina,et al.  Profiling of benzophenone derivatives using fish and human estrogen receptor-specific in vitro bioassays. , 2008, Toxicology and applied pharmacology.

[46]  J. Toppari Environmental Endocrine Disrupters , 2008, Sexual Development.

[47]  Gerald T Ankley,et al.  Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[48]  Peter Tontonoz,et al.  Fat and beyond: the diverse biology of PPARgamma. , 2008, Annual review of biochemistry.

[49]  Kevin M Crofton,et al.  Thyroid disrupting chemicals: mechanisms and mixtures. , 2008, International journal of andrology.

[50]  H. Gronemeyer,et al.  Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function , 2007, Proceedings of the National Academy of Sciences.

[51]  Y. Shimohigashi,et al.  Direct Evidence Revealing Structural Elements Essential for the High Binding Ability of Bisphenol A to Human Estrogen-Related Receptor-γ , 2007, Environmental health perspectives.

[52]  Y. Lévi,et al.  A new bioluminescent cellular assay to measure the transcriptional effects of chemicals that modulate the alpha-1 thyroid hormone receptor. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[53]  Shiuan Chen,et al.  ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer. , 2007, Cancer research.

[54]  Wissem Mnif,et al.  Estrogens and antiestrogens activate hPXR. , 2007, Toxicology letters.

[55]  J. Bernal Thyroid hormone receptors in brain development and function , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[56]  B. Spiegelman,et al.  International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors , 2006, Pharmacological Reviews.

[57]  Gregor Eichele,et al.  International Union of Pharmacology. LXIII. Retinoid X Receptors , 2006, Pharmacological Reviews.

[58]  D. Zalko,et al.  Steroid receptor profiling of vinclozolin and its primary metabolites. , 2006, Toxicology and applied pharmacology.

[59]  R. Evans,et al.  Anatomical Profiling of Nuclear Receptor Expression Reveals a Hierarchical Transcriptional Network , 2006, Cell.

[60]  Wissem Mnif,et al.  Identification of new human pregnane X receptor ligands among pesticides using a stable reporter cell system. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[61]  J. Cravedi,et al.  Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. , 2006, Biochemical pharmacology.

[62]  B. Blumberg,et al.  New modes of action for endocrine-disrupting chemicals. , 2006, Molecular endocrinology.

[63]  A. Pike Lessons learnt from structural studies of the oestrogen receptor. , 2006, Best practice & research. Clinical endocrinology & metabolism.

[64]  L. Bláha,et al.  Environmental xenobiotics and nuclear receptors--interactions, effects and in vitro assessment. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[65]  Denise G. Teotico,et al.  The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges. , 2005, Molecular endocrinology.

[66]  Arnaud Pillon,et al.  Differential responses of PPARα, PPARδ, and PPARγ reporter cell lines to selective PPAR synthetic ligands , 2005 .

[67]  M. Sasaki,et al.  Evaluation of estrogenic activities of pesticides using an in vitro reporter gene assay , 2005, International journal of environmental health research.

[68]  G. Veeneman,et al.  Non-steroidal subtype selective estrogens. , 2005, Current medicinal chemistry.

[69]  J. Nicolas,et al.  Estrogenic Activity of Cosmetic Components in Reporter Cell Lines: Parabens, UV Screens, and Musks , 2005, Journal of toxicology and environmental health. Part A.

[70]  Georges de Sousa,et al.  A PXR reporter gene assay in a stable cell culture system: CYP3A4 and CYP2B6 induction by pesticides. , 2004, Biochemical pharmacology.

[71]  Vincent Laudet,et al.  Principles for modulation of the nuclear receptor superfamily , 2004, Nature Reviews Drug Discovery.

[72]  L Earl Gray,et al.  Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[73]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[74]  J. Nishikawa,et al.  Endocrine disruptors induce cytochrome P450 by affecting transcriptional regulation via pregnane X receptor. , 2003, Toxicology and applied pharmacology.

[75]  Yate-Ching Yuan,et al.  Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. , 2003, Molecular cancer research : MCR.

[76]  L. Moore,et al.  2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. , 2003, Biochemistry.

[77]  K. Dahlman-Wright,et al.  Estrogen Receptor (ER)-β Reduces ERα-Regulated Gene Transcription, Supporting a “Ying Yang” Relationship between ERα and ERβ in Mice , 2003 .

[78]  B. Térouanne,et al.  Evaluation of androgenic bioactivity in human serum by recombinant cell line: preliminary results , 2002, Molecular and Cellular Endocrinology.

[79]  E. Ariazi,et al.  Estrogen-related Receptor α and Estrogen-related Receptor γ Associate with Unfavorable and Favorable Biomarkers, Respectively, in Human Breast Cancer , 2002 .

[80]  H. Gronemeyer,et al.  TIF2 Mediates the Synergy between RARα1 Activation Functions AF-1 and AF-2* , 2002, The Journal of Biological Chemistry.

[81]  Lyndon Warfe,et al.  A Cell-Based Reporter Gene Assay for Determining Induction of CYP3A4 in a High-Volume System , 2002, Journal of Pharmacology and Experimental Therapeutics.

[82]  Chris Albanese,et al.  Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression* , 2002, The Journal of Biological Chemistry.

[83]  V. Giguère To ERR in the estrogen pathway , 2002, Trends in Endocrinology & Metabolism.

[84]  T. Zoeller,et al.  Thyroid hormone, brain development, and the environment. , 2002, Environmental health perspectives.

[85]  P. Manow ‚The Good, the Bad, and the Ugly‘ , 2002 .

[86]  Paula Baillie-Hamilton Chemical toxins: a hypothesis to explain the global obesity epidemic. , 2002, Journal of alternative and complementary medicine.

[87]  L. Gray,et al.  A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[88]  D. Moras,et al.  Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. , 2002, Molecular cell.

[89]  H. Gronemeyer,et al.  Co-regulator recruitment and the mechanism of retinoic acid receptor synergy , 2002, Nature.

[90]  K. Lee,et al.  Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. , 2001, Cancer research.

[91]  J. Nicolas,et al.  Environmental xenoestrogens, antiandrogens and disorders of male sexual differentiation , 2001, Molecular and Cellular Endocrinology.

[92]  B. M. Forman,et al.  The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux , 2001, Nature Medicine.

[93]  T. Perlmann,et al.  Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. , 2000, Science.

[94]  D. Moras,et al.  Structural studies on nuclear receptors , 2000, Cellular and Molecular Life Sciences CMLS.

[95]  J. Gustafsson,et al.  Estrogen receptor β acts as a dominant regulator of estrogen signaling , 2000, Oncogene.

[96]  H. Gronemeyer,et al.  Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. , 2000, Trends in pharmacological sciences.

[97]  J. Schwabe,et al.  St John's wort, a herbal antidepressant, activates the steroid X receptor. , 2000, The Journal of endocrinology.

[98]  P. Chambon,et al.  Synergy between estrogen receptor α activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2 , 2000, EMBO reports.

[99]  J. A. Kemppainen,et al.  FXXLF and WXXLF Sequences Mediate the NH2-terminal Interaction with the Ligand Binding Domain of the Androgen Receptor* , 2000, The Journal of Biological Chemistry.

[100]  E. Jensen,et al.  Estrogen receptor (ER) , a modulator of ER in the uterus , 2000 .

[101]  F. Orio,et al.  A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects , 2000, Molecular and Cellular Endocrinology.

[102]  W. Wahli,et al.  Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.

[103]  C. Yang,et al.  Two organochlorine pesticides, toxaphene and chlordane, are antagonists for estrogen-related receptor alpha-1 orphan receptor. , 1999, Cancer research.

[104]  J. Nicolas,et al.  Reporter cell lines to study the estrogenic effects of xenoestrogens. , 1999, The Science of the total environment.

[105]  J. Gustafsson,et al.  Transcriptional targets shared by estrogen receptor‐related receptors (ERRs) and estrogen receptor (ER) α, but not by ERβ , 1999 .

[106]  K. Korach,et al.  Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.

[107]  D. Pfaff,et al.  Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice. , 1998, Endocrinology.

[108]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[109]  J. Lehmann,et al.  The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. , 1998, The Journal of clinical investigation.

[110]  J. Gustafsson,et al.  Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. , 1998, Molecular pharmacology.

[111]  R. Evans,et al.  The RXR heterodimers and orphan receptors , 1995, Cell.

[112]  Gregor Eichele,et al.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor , 1992, Cell.

[113]  E. Wilson Analysis of interdomain interactions of the androgen receptor. , 2011, Methods in molecular biology.

[114]  B. van der Burg,et al.  Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds. , 2010, Reproductive toxicology.

[115]  Hélène Budzinski,et al.  Evaluation of an hPXR reporter gene assay for the detection of aquatic emerging pollutants: screening of chemicals and application to water samples , 2010, Analytical and bioanalytical chemistry.

[116]  P. Balaguer,et al.  Activation of alpha- and beta-estrogen receptors by persistent pesticides in reporter cell lines. , 2006, Life sciences.

[117]  J. Nicolas,et al.  Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands. , 2005, Analytical biochemistry.

[118]  K. Dahlman-Wright,et al.  Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. , 2003, Molecular endocrinology.

[119]  H. Gronemeyer,et al.  TIF2 mediates the synergy between RARalpha 1 activation functions AF-1 and AF-2. , 2002, The Journal of biological chemistry.

[120]  Chris Albanese,et al.  Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. , 2002, The Journal of biological chemistry.

[121]  J. Berger,et al.  The mechanisms of action of PPARs. , 2002, Annual review of medicine.

[122]  J. Gustafsson,et al.  Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[123]  J. Gustafsson,et al.  Estrogen receptor beta acts as a dominant regulator of estrogen signaling. , 2000, Oncogene.

[124]  J. Gustafsson,et al.  Transcriptional targets shared by estrogen receptor- related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ERbeta. , 1999, The EMBO journal.

[125]  J. Corton,et al.  Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. , 1998, Endocrinology.

[126]  N. Sobol,et al.  Preliminary results , 2020, Asymptotic Analysis of Random Walks: Light-Tailed Distributions.